First Implant to Treat Opioid Addiction Gets FDA Approval

  • Titan product delivers drug continuously for six months
  • Treatment will be limited to stable patients on low doses

How Prescription Drugs Sparked America's Heroin Epidemic

Titan Pharmaceuticals Inc. and partner Braeburn Pharmaceuticals won approval for the first implant in the U.S. to treat heroin and opioid painkiller addictions, which have reached epidemic levels.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.